NCT06991101: An ongoing trial by Baptist Health South Florida
This trial is ongoing. It must report results 5 years, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06991101 |
|---|---|
| Title | Randomized Phase 2 Trial of Ruxolitinib in Combination With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma. |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 3, 2025 |
| Completion date | Dec. 31, 2030 |
| Required reporting date | Dec. 31, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 15, 2026 |
| Days late | None |